These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9108670)

  • 21. Cranially irradiated adult cancer survivors may have normal spontaneous GH secretion in the presence of discordant peak GH responses to stimulation tests (compensated GH deficiency).
    Darzy KH; Thorner MO; Shalet SM
    Clin Endocrinol (Oxf); 2009 Feb; 70(2):287-93. PubMed ID: 18673465
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Oral hydrocortisone administration in children with classic 21-hydroxylase deficiency leads to more synchronous joint GH and cortisol secretion.
    Charmandari E; Pincus SM; Matthews DR; Johnston A; Brook CG; Hindmarsh PC
    J Clin Endocrinol Metab; 2002 May; 87(5):2238-44. PubMed ID: 11994370
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of aging on the sensitivity of growth hormone secretion to insulin-like growth factor-I negative feedback.
    Chapman IM; Hartman ML; Pezzoli SS; Harrell FE; Hintz RL; Alberti KG; Thorner MO
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2996-3004. PubMed ID: 9284733
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life.
    Aguiar-Oliveira MH; Gill MS; de A Barretto ES; Alcântara MR; Miraki-Moud F; Menezes CA; Souza AH; Martinelli CE; Pereira FA; Salvatori R; Levine MA; Shalet SM; Camacho-Hubner C; Clayton PE
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4118-26. PubMed ID: 10566659
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacodynamic hormonal effects of anamorelin, a novel oral ghrelin mimetic and growth hormone secretagogue in healthy volunteers.
    Garcia JM; Polvino WJ
    Growth Horm IGF Res; 2009 Jun; 19(3):267-73. PubMed ID: 19196529
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Abdominal visceral fat and fasting insulin are important predictors of 24-hour GH release independent of age, gender, and other physiological factors.
    Clasey JL; Weltman A; Patrie J; Weltman JY; Pezzoli S; Bouchard C; Thorner MO; Hartman ML
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3845-52. PubMed ID: 11502822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Joint growth hormone and cortisol spontaneous secretion is more asynchronous in older females than in their male counterparts.
    Charmandari E; Pincus SM; Matthews DR; Dennison E; Fall CH; Hindmarsh PC
    J Clin Endocrinol Metab; 2001 Jul; 86(7):3393-9. PubMed ID: 11443216
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subnormal serum insulin-like growth factor-I levels in young adults with childhood-onset nonacquired growth hormone (GH) deficiency who recover normal gh secretion may indicate less severe but persistent pituitary failure.
    Gelwane G; Garel C; Chevenne D; Armoogum P; Simon D; Czernichow P; Léger J
    J Clin Endocrinol Metab; 2007 Oct; 92(10):3788-95. PubMed ID: 17666477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of recombinant human insulin-like growth factor I administration on growth hormone (GH) secretion, both spontaneous and stimulated by GH-releasing hormone or hexarelin, a peptidyl GH secretagogue, in humans.
    Ghigo E; Gianotti L; Arvat E; Ramunni J; Valetto MR; Broglio F; Rolla M; Cavagnini F; Müller EE
    J Clin Endocrinol Metab; 1999 Jan; 84(1):285-90. PubMed ID: 9920097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
    Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
    J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Update on new therapeutic options for the somatopause.
    Ceda GP; Dall'Aglio E; Morganti S; Denti L; Maggio M; Lauretani F; Andrea A; Ceresini G; Cattabiani C; Valenti G
    Acta Biomed; 2010; 81 Suppl 1():67-72. PubMed ID: 20518193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nutritional and endocrine-metabolic aberrations in women with functional hypothalamic amenorrhea.
    Laughlin GA; Dominguez CE; Yen SS
    J Clin Endocrinol Metab; 1998 Jan; 83(1):25-32. PubMed ID: 9435412
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of aging and estradiol supplementation on GH axis dynamics in women.
    Lieman HJ; Adel TE; Forst C; von Hagen S; Santoro N
    J Clin Endocrinol Metab; 2001 Aug; 86(8):3918-23. PubMed ID: 11502833
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Insulin-like growth factor-1 and growth hormone (GH) levels in canine cerebrospinal fluid are unaffected by GH or GH secretagogue (MK-0677) administration.
    Prahalada S; Block G; Handt L; DeBurlet G; Cahill M; Hoe CM; van Zwieten MJ
    Horm Metab Res; 1999; 31(2-3):133-7. PubMed ID: 10226793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Unequal impact of short-term testosterone repletion on the somatotropic axis of young and older men.
    Gentili A; Mulligan T; Godschalk M; Clore J; Patrie J; Iranmanesh A; Veldhuis JD
    J Clin Endocrinol Metab; 2002 Feb; 87(2):825-34. PubMed ID: 11836328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MK-0677, a potent, novel, orally active growth hormone (GH) secretagogue: GH, insulin-like growth factor I, and other hormonal responses in beagles.
    Jacks T; Smith R; Judith F; Schleim K; Frazier E; Chen H; Krupa D; Hora D; Nargund R; Patchett A; Hickey G
    Endocrinology; 1996 Dec; 137(12):5284-9. PubMed ID: 8940347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of the growth hormone-insulin-like growth factor I axis in developing and adult monkeys is affected by estradiol replacement and supplementation with insulin-like growth factor I.
    Wilson ME
    J Clin Endocrinol Metab; 1998 Jun; 83(6):2018-28. PubMed ID: 9626134
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The pharmacokinetics, pharmacodynamics, safety and tolerability of a single dose of NN703, a novel orally active growth hormone secretagogue in healthy male volunteers.
    Zdravkovic M; Søgaard B; Ynddal L; Christiansen T; Agersø H; Thomsen MS; Falch JE; Ilondo MM
    Growth Horm IGF Res; 2000 Aug; 10(4):193-8. PubMed ID: 11032702
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Does growth hormone prevent aging in the healthy elderly with low serum insulin-like growth factor-I ?
    Lee KO; Liao L; Mukherjee JJ
    Mech Ageing Dev; 2004 Apr; 125(4):291-5. PubMed ID: 15063105
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.